Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating)’s share price rose 1.5% during mid-day trading on Friday . The stock traded as high as $1.35 and last traded at $1.35. Approximately 12,315 shares changed hands during trading, a decline of 77% from the average daily volume of 54,536 shares. The stock had previously closed at $1.33. […]
Dr John Friend, chief medical officer (CMO) of Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) will immediately assume the role of chief executive officer.
Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 141,400 shares, an increase of 10.0% from the March 15th total of 128,600 shares. Based on an average daily trading volume, of 53,000 shares, […]
Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 141,400 shares, a growth of 10.0% from the March 15th total of 128,600 shares. Based on an average daily trading volume, of 53,000 shares, the short-interest ratio […]
Week in review: ASX climbs; what will Easter weekend bring to the market?; has Australia s property market seen the bottom? proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.